Navigation Links
BioDiscovery Joins Illumina Connect Bioinformatics Program

- Integrates Nexus CGH with Illumina's BeadStudio Software -

EL SEGUNDO, Calif., Nov. 13 /PRNewswire/ -- BioDiscovery announced today that it joined Illumina Connect, a bioinformatics program offered by Illumina, Inc., for downstream analysis of microarray data. After collaborating with Illumina, BioDiscovery has successfully created an interface that allows customers using both Illumina's BeadStudio software to seamlessly process their data in BioDiscovery's Nexus CGH advanced copy number analysis software.

Nexus CGH is BioDiscovery's platform-independent solution for the analysis and visualization of multiple samples for identification of regions of chromosomal gain and loss in a population, and performing statistical association studies. Nexus CGH can easily handle large projects including those with thousands of Illumina high-density arrays.

Omoshile Clement, Ph.D., Illumina's Senior Product Manager of Platforms said, "Interest in Illumina Connect has continued to grow because bioinformatics software and service providers recognize the value that Illumina technology brings to their customers. Now that BioDiscovery is a partner, we are excited to work with them to make it easier for customers to access the power of Illumina's genotyping applications for their studies."

"BioDiscovery's drive for platform independence has been realized with Nexus CGH, said Dr. Soheil Shams, President of BioDiscovery. "We are delighted to work with Illumina to create an interface between our products, and to create greater value for scientists and the medical community looking to advance their downstream analysis functionality," said Dr. Shams.

"The user-friendly Nexus interface enables researchers to answer important biological questions without the need for advanced statistical or programming knowledge. With the integration of Illumina's BeadStudio and Nexus CGH, our customers can go from raw data to biological insight in a matter of minutes," said Dr. Shams.

About BioDiscovery, Inc.

BioDiscovery is a leader in the development of microarray advanced bioinformatics software and services that enable its customers to revolutionize drug discovery and diagnostics by efficiently managing, integrating, and analyzing data generated using high-throughput microarray technology. Contact us: 310-414-8100 or


Soheil Shams


BioDiscovery, Inc.

310.414.8100 x221

SOURCE BioDiscovery, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. BioDiscovery Releases NEXUS CGH Version 2 for DNA Copy Number Analysis and Visualization
2. Richard Greco Joins Mediware Board
3. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
4. Sean P. McLaughlin Joins Red Cross as Chief of Operations Support
5. Dr. Mahesh Ramachandran Joins Marianjoy Medical Group
6. Nick Childs Joins Grey New York as Director of Content Development
7. Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book
8. David Ward Joins OrthoSynetics(TM) as Western Region Sales Manager
9. NASN Joins Partnership to Fight Chronic Disease
10. AstraZeneca Joins Local Walking Movement
11. Proxy Governance Joins ISS, Glass Lewis and Egan Jones in Recommending Arrow International Shareholders Vote to Approve the $45.50 Per Share Merger With Teleflex
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... A simply groundbreaking television series, "Voices in ... that delves into an array of issues that are presently affecting Americans. Dedicated to ... dialogue, this show is changing the subjects consumers focus on, one episode at a ...
(Date:11/27/2015)... ... November 27, 2015 , ... The men ... prominent nonprofit healthcare organizations in the country. They have overseen financial turnarounds, shown ... helped advance the healthcare industry as a whole through their advocacy and professional ...
(Date:11/26/2015)... ... November 26, 2015 , ... Patients ... central Michigan, have come together on Thanksgiving Day to share the things that ... viewing on the Serenity Point YouTube channel, patients displayed what they wrote on ...
(Date:11/26/2015)... , ... November 26, 2015 , ... ... workshops to discuss bioavailability and the need to integrate dose form selection in ... collaboration with OBN, the membership organization supporting and bringing together the UK’s emerging ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... retro-fused, self-animating trailer titles with ProTrailer: Vintage. This newly styled ProTrailer pack comes ... titles work with any font, giving users limitless opportunities to stylize and create ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... -- --> --> ... potential to save costs, improve treatment quality and accelerate ... exploited as yet. Here, particular emphasis is placed on ... tablet or directly at the patients, bedside. ... -->      (Photo: ) ...
(Date:11/27/2015)... -- Research and Markets ( ) has announced ... 2015-2019" report to their offering. ... the author the present scenario and growth prospects of ... the market size, the report considers revenue generated from ... and copper IUDs. The report forecasts the global intrauterine ...
(Date:11/26/2015)... 26, 2015 Un nuevo enfoque ... para el cáncer avanzado.   --> ... fotodinámica de Bremachlorin para el cáncer avanzado.   ... inmunoterapia con la terapia fotodinámica de Bremachlorin para el ... . --> Clinical Cancer Research . ...
Breaking Medicine Technology: